| Multiple testing problems in pharmaceutical statistics A Dmitrienko, AC Tamhane, F Bretz CRC press, 2009 | 396* | 2009 |
| Subgroup identification based on differential effect search—a recursive partitioning method for establishing response to treatment in patient subpopulations I Lipkovich, A Dmitrienko, J Denne, G Enas Statistics in medicine 30 (21), 2601-2621, 2011 | 347 | 2011 |
| Tutorial in biostatistics: data‐driven subgroup identification and analysis in clinical trials I Lipkovich, A Dmitrienko, R B D'Agostino Sr Statistics in medicine 36 (1), 136-196, 2017 | 296 | 2017 |
| Analysis of clinical trials using SAS: a practical guide A Dmitrienko SAS institute, 2017 | 251 | 2017 |
| Innovative approaches for designing and analyzing adaptive dose-ranging trials B Bornkamp, F Bretz, A Dmitrienko, G Enas, B Gaydos, CH Hsu, F König, ... Journal of biopharmaceutical statistics 17 (6), 965-995, 2007 | 220 | 2007 |
| Traditional multiplicity adjustment methods in clinical trials A Dmitrienko, R D'Agostino Sr Statistics in Medicine 32 (29), 5172-5218, 2013 | 159 | 2013 |
| General multistage gatekeeping procedures A Dmitrienko, AC Tamhane, BL Wiens Biometrical Journal: Journal of Mathematical Methods in Biosciences 50 (5 …, 2008 | 146 | 2008 |
| Tree‐structured gatekeeping tests in clinical trials with hierarchically ordered multiple objectives A Dmitrienko, BL Wiens, AC Tamhane, X Wang Statistics in medicine 26 (12), 2465-2478, 2007 | 130 | 2007 |
| Multiple co-primary endpoints: medical and statistical solutions: a report from the multiple endpoints expert team of the Pharmaceutical Research and Manufacturers of America W Offen, C Chuang-Stein, A Dmitrienko, G Littman, J Maca, L Meyerson, ... Drug information journal 41 (1), 31-46, 2007 | 129 | 2007 |
| Pharmaceutical statistics using SAS: a practical guide A Dmitrienko, C Chuang-Stein, RB D'Agostino SAS Institute, 2007 | 125 | 2007 |
| LY315920NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis BG Zeiher, J Steingrub, PF Laterre, A Dmitrienko, Y Fukiishi, E Abraham, ... Critical care medicine 33 (8), 1741-1748, 2005 | 123 | 2005 |
| Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure E Abraham, C Naum, V Bandi, D Gervich, SF Lowry, R Wunderink, ... Critical care medicine 31 (3), 718-728, 2003 | 122 | 2003 |
| Methods for identification and confirmation of targeted subgroups in clinical trials: a systematic review T Ondra, A Dmitrienko, T Friede, A Graf, F Miller, N Stallard, M Posch Journal of biopharmaceutical statistics 26 (1), 99-119, 2016 | 121 | 2016 |
| Gatekeeping procedures with clinical trial applications A Dmitrienko, AC Tamhane Pharmaceutical Statistics: The Journal of Applied Statistics in the …, 2007 | 120 | 2007 |
| Multiplicity considerations in clinical trials A Dmitrienko, RB D’Agostino Sr New England Journal of Medicine 378 (22), 2115-2122, 2018 | 117 | 2018 |
| Strategies for identifying predictive biomarkers and subgroups with enhanced treatment effect in clinical trials using SIDES I Lipkovich, A Dmitrienko Journal of biopharmaceutical statistics 24 (1), 130-153, 2014 | 117 | 2014 |
| Key multiplicity issues in clinical drug development A Dmitrienko, RB D'Agostino Sr, MF Huque Statistics in medicine 32 (7), 1079-1111, 2013 | 109 | 2013 |
| Challenge of multiple co‐primary endpoints: a new approach C Chuang‐Stein, P Stryszak, A Dmitrienko, W Offen Statistics in medicine 26 (6), 1181-1192, 2007 | 80 | 2007 |
| Mixtures of multiple testing procedures for gatekeeping applications in clinical trials A Dmitrienko, AC Tamhane Statistics in medicine 30 (13), 1473-1488, 2011 | 70 | 2011 |
| Stepwise gatekeeping procedures in clinical trial applications A Dmitrienko, AC Tamhane, X Wang, X Chen Biometrical Journal: Journal of Mathematical Methods in Biosciences 48 (6 …, 2006 | 70 | 2006 |
